Valeant Pharma (VRX) volatility spikes after Left said to take new short
Valeant Pharma (NYSE: VRX) July call option implied volatility is at 123, compared to closing level of 82 last night, August is at 94, compared to a closing level of 86, after Citron's Andrew Left said to take a new short stake and says worth $0.
